PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects Prostate Cancer," (1) demonstrating clinical validation ...

PanGIA Biotech Non-Invasive Cancer Detection Abstracts Accepted for Presentation at AACR Annual Meeting 2026

PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
Orange County Business Journal

Helio Genomics Enters Full Launch with Quest Diagnostics

Irvine-based Helio Genomics announces partnership with Quest Diagnostics to distribute its liver cancer detection test ...

TOBY Receives FDA Breakthrough Device Designation for Its Urine-Based Multi-Cancer Early Detection (MCED) Test

TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...

Simple and Cheap Blood Test Could Detect Cancer and Other Diseases Before Symptoms Appear

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.
Hoodline

Cambridge Cancer-Test Upstart Grabs $100 Million Before Screening Starts

Harbinger Health, a Cambridge biotech spun out of Flagship, says it has locked in $100 million in new financing as it races ...

NovaScan Appoints Bob Cook as Chief Operating Officer to Accelerate Commercialization of MarginScan™ Platform

Former Castle Biosciences SVP brings proven diagnostic commercialization and reimbursement leadership to NovaScan’s ...
Medical Xpress

A machine learning model may enable liver cancer risk prediction with routine clinical information

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
The Harvard Crimson

Harvard Researchers Develop Novel Early-Detection Tool for HPV-Caused Cancer

{image id=1352663 align=left size=large byline=true caption="The Massachusetts General Hospital, home to Mass Eye and Ear and part of the Mass General Brigham system ...